Omega-3

Omega-3s in Food and Beverage

Enzymotec (Migdal HaEmeq, Israel) and Mercola.com have co-launched Krill-IQ, a product containing krill-derived phosphatidylserine (PS) and an omega-3/astaxanthin complex of krill and alpha-glycerylphosphorylcholine (Alpha-GPC).

The new omega-3 player is producing algae-based omega-3 eicosapentaenoic acid (EPA).

For an omega-3 market increasing in variety, NP Nutra (Rancho Dominguez, CA) has now introduced SachaOmega oil, a certified organic and cold-pressed oil containing omega-3s, omega-6s, and omega-9s along with a 1.4-to-1 ratio of omega-3 to omega-6.

As the functional food industry grows at a rapid pace, Leatherhead Food Research (Leatherhead, UK) is proposing that marine-derived ingredients could be the answer for product distinction in competitive food and beverage markets.

IOM recommends the Department of Defense prioritize research on these interventions.

Summarized here are some of the studies relevant to carotenoids and omega-3 fatty acids.

A look at today’s options in a growing omega-3 market.

EPAX AS (Aalesund, Norway), a global supplier of omega-3 fish oils, has been named a 2011 top supplier by soft-gelatin specialist Banner Pharmacaps Inc. (High Point, NC) at Banner’s recent “Partners in Success” awards ceremony.

Omega-3 ingredient supplier EPAX AS (Aalesund, Norway) has received a “Friend of the Sea” award (in the omega-3 category) from Friend of the Sea (FOS), a nonprofit certifier of sustainable fishing and aquaculture projects.

A study published in the American Journal of Epidemiology has associated omega-3 intake with an increased risk of prostate cancer-results that even surprised the researchers, who urged that their findings not be taken too seriously yet.

After a successful 2010 market test with its Arctic Wonder krill oil brand, Bayer Healthcare LLC’s (Morristown, NJ) consumer care division has officially launched its Arctic Wonder krill oil dietary supplement.

The organization cites limitations to a study published in the American Journal of Clinical Nutrition, which found no benefit of maternal DHA supplementation on infant visual acuity.

The New Zealand-based company is gearing up for industrial production of pharmaceutical-grade algal omega-3.

Pharmaceutical company Amarin Corp. (Mystic, CN) will present data from its MARINE trial, a Phase III study investigating omega-3 drug AMR101 as a treatment for very high triglycerides.

The company will address needs in personal nutrition, aquaculture, and biofuel with a single crop.

Food frequency questionnaires showed that lower omega-6 to omega-3 ratios were best for improving asthma control.

Researchers calculated U.S. consumption patterns from 1909 to 1999 by following the availability of essential fatty acids in 373 food commodities over the course of that time.

OptiSol 5000 is a natural flax-based ingredient designed to improve the texture of pizza dough by enhancing extensibility and workability.

A research group based in Italy has found that krill oil may be more efficient in activating fat metabolism than fish oil.

Emerging research is unlocking the cognitive-health potential of numerous dietary supplement ingredients.

Emerging delivery systems are spicing things up for functional ingredients.

As of March, the company is handling its own direct distribution for its Superba krill ingredients in North America.

The trial is called EVOLVE and will evaluate the efficacy and safety of the drug, geared to patients with very high triglycerides.

Reflections from the first annual GOED Exchange.

Reflections from the first annual GOED Exchange.

Probiomega is a new, unique probiotic ingredient that features an omega-3 “shield” that helps protect the bacteria.

Nordic Naturals is promoting its Kenai Wild Alaskan Salmon Oil, which the company says is the first salmon oil in the market to pass all international standards for purity.

The new website does not appear to attack industry over contaminants, but rather provides information to educate consumers.

An assessment of the diets of 38,022 women has concluded that higher fish consumption is associated with reduced risk of age-related macular degeneration (AMD) by as much as 42%.